Avid Bioservices Inc (CDMO): PR 4-5-10: Avid & Halozyme Expand Commer...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	72
Posts	4827
Boards Moderated	0
Alias Born	01/24/2004

cjgaddy

Re: None

Monday, 04/05/2010 5:37:34 PM

Monday, April 05, 2010 5:37:34 PM

PR 4-5-10: Avid & Halozyme Expand Commercial Supply Relationship

“Avid Bioservices and Halozyme Therapeutics Expand Commercial Supply Relationship With New Manufacturing Agreements - Avid Designated a Preferred Supplier for Halozyme”
http://ir.peregrineinc.com/releasedetail.cfm?ReleaseID=456456

TUSTIN, April 5 2010: Avid Bioservices, Inc., a wholly-owned subsidiary of Peregrine Pharmaceuticals, Inc. (PPHM), today announced that it has expanded its commercial supply relationship with Halozyme Therapeutics, Inc. with new manufacturing agreements. The companies have also entered into a long-term strategic relationship with Halozyme designating Avid a preferred supplier for future products requiring Avid's process development and biomanufacturing capabilities and expertise. Avid has manufactured commercial product for Halozyme since 2005 in the company's current cGMP facility.

As part of the new agreements, the companies have amended and extended their existing commercial supply agreement for recombinant human hyaluronidase ("rHuPH20"), used in 2 of Halozyme's marketed products. In addition, the companies have signed a new commercial supply agreement for additional rHuPH20 products. Specific financial terms of these commercial supply agreements have not been disclosed.

"We are pleased to strengthen our already robust supply chain for rHuPH20 with these new agreements with Avid, supporting our existing products as well as partnered product candidates," said Jonathan E. Lim, M.D., Halozyme's president and CEO. "Expanding our commercial supply relationship with Avid is a testament to the strong relationship we have developed over the past 5 years."

"We are delighted to extend the Hylenex & Cumulase supply agreement, and expand our long-term relationship with Halozyme as we partner with them to support their current & future commercial and clinical process dev. and biomanufacturing needs," said Christopher E. Eso, Avid's VP, business operations. "Our solid client relationships and dedicated team at Avid have been critical to ensuring our clients' success."

ABOUT AVID BIOSERVICES
Avid Bioservices provides a comprehensive range of cGMP manufacturing services for the biotechnology and biopharmaceutical industries. Avid manufactures cGMP commercial product, as well as clinical supplies for all phases of clinical trials. The company's comprehensive range of cGMP services includes cell banking, stability testing, clinical and commercial product manufacturing and purification, bulk packaging, final product filling and regulatory support. Avid also provides a variety of process development activities, including cell line optimization, analytical method development and product characterization. The company has over 10 years of antibody manufacturing experience producing monoclonal antibodies and recombinant proteins in batch, fed-batch and perfusion modes. For more information about Avid, visit http://www.avidbio.com .
CONTACTS:
Avid Bioservices: Chris Eso, VP, Business Operations, (714) 508-6190
Media: GendeLLindheim BioCom Partners, Barbara Lindheim, (212) 918-4650

= = = = = = =
HALO announced on 4-5-10 that it had amended the 2006 supply agreement with Avid and added a new with Avid (and a 2nd new one with Cook-Pharmic) to cover “the commercial production rHuPH20 to be used in the mfg. of both current products as well as certain partnered product candidates such as subcutaneous HERCEPTIN & GAMMAGARD with rHuPH20. Subcutaneous Herceptin and GAMMAGARD with rHuPH20 are both currently in Phase 3 clinical trials.”
http://phx.corporate-ir.net/phoenix.zhtml?c=175436&p=irol-newsArticle&ID=1409382

= = = = = = = = = = =
Avid’s CMO relationship with HALO goes back to early 2005:
2-17-05: “Avid Signs Comm. Mfg. Contract with Halozyme…” http://tinyurl.com/6rbwzg
12-6-05: “Avid Begins 1st Comm. Stage Drug Mfg. Project – Hylenex…” http://tinyurl.com/5oryz3
12-6-06: “Halozyme shares soar on Roche deal over Enhanze” http://tinyurl.com/6ch2mf
12-19-06: ”Avid & Halozyme Extend Mfg. Agreement…” http://tinyurl.com/62wp67
4-5-10: ”Avid & Halozyme Add New Mfg. Agreement for ‘new partnered products’…” http://tinyurl.com/yfdgsom